Bladder Preservation for Patients With Muscle Invasive Bladder Cancer (MIBC) With Variant Histology

PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 1, 2025

Primary Completion Date

October 31, 2030

Study Completion Date

October 31, 2030

Conditions

Muscle-Invasive Bladder CarcinomaTumor

Interventions

DRUG

Trimodal therapy (TMT) within 45 days of neoadjuvant chemotherapy (NAC)

Single-arm, open-label

Trial Locations (1)

RECRUITING

Cedars Sinai Medical Center, Los Angeles

All Listed Sponsors

lead

Leslie Ballas

OTHER